Shoei-Sheng Lee

Title: The Innovations of Shoei-Sheng Lee

Introduction

Shoei-Sheng Lee is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of ocular disease treatment and metabolic regulation through his innovative patents. With a total of 5 patents, Lee's work has the potential to impact many lives.

Latest Patents

One of his latest patents is a method for treating ocular diseases, which includes age-related macular degeneration (AMD), diabetic retinopathy (DR), and macular edema (ME). This invention involves administering a composition that contains a therapeutically effective amount of beauvericin. Another notable patent is for an isoquinoline alkaloid derivative aimed at activating AMP-dependent protein kinase (AMPK). This method involves administering a pharmaceutical composition that includes a compound with a specific formula, such as salsolinol or reticuline, which can effectively regulate cell growth and metabolism.

Career Highlights

Throughout his career, Shoei-Sheng Lee has worked with various organizations, including Zih Yuan Tang Biotechnology Co., Ltd. and the National Science Council. His experience in these institutions has allowed him to develop and refine his innovative ideas.

Collaborations

Lee has collaborated with notable colleagues, including Ming-Jai Su and Chao-Min Hsu, which has further enriched his research and development efforts.

Conclusion

Shoei-Sheng Lee's contributions to the field of innovation, particularly in ocular disease treatment and metabolic regulation, highlight his role as a significant inventor. His patents reflect a commitment to advancing medical science and improving patient outcomes.